Viewing Study NCT01468532


Ignite Creation Date: 2025-12-24 @ 9:24 PM
Ignite Modification Date: 2026-02-23 @ 1:53 PM
Study NCT ID: NCT01468532
Status: COMPLETED
Last Update Posted: 2021-03-25
First Post: 2011-10-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Sponsor: Barbara Ann Karmanos Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adenocarcinoma of the Prostate View
None Hormone-resistant Prostate Cancer View
None Recurrent Prostate Cancer View
None Stage IV Prostate Cancer View
Keywords: